Jackson Creek Investment Advisors LLC Ligand Pharmaceuticals Inc Transaction History
Jackson Creek Investment Advisors LLC
- $338 Million
- Q3 2024
A detailed history of Jackson Creek Investment Advisors LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 17,476 shares of LGND stock, worth $2.04 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
17,476
Previous 13,600
28.5%
Holding current value
$2.04 Million
Previous $1.15 Million
52.62%
% of portfolio
0.52%
Previous 0.42%
Shares
10 transactions
Others Institutions Holding LGND
# of Institutions
259Shares Held
18MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$335 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$230 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$118 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$103 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$82.4 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.97B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...